Aldurazyme savings card from the maker

Aldurazyme is given by a doctor or nurse and billed by the clinic, not a pharmacy. Your care team and your insurance decide which product you get, so ask them what you’d pay.

How to pay the least

Given by your care team

Billed by the clinic

Aldurazyme is given by a doctor or nurse, not picked up at a pharmacy.

Ask your care team or your plan what you’d pay before your visit.

Compare every option

Brand nameAldurazyme

Authorized genericlaronidase

Regular genericlaronidase

What you’d pay

Cash priceAsk the pharmacy

Not soldThere isn’t one

Not soldAsk the pharmacy

Same as Aldurazyme?

The original

–

Brand nameThe maker’s card

Aldurazyme Copay Program (CareConnect Copay Program)

Savings card from Sanofi

Aldurazyme’s maker has a savings program. Its page doesn’t list a dollar amount.

Print the card (PDF)

Or call 1-800-745-4447. See the offer on aldurazyme.com

From the maker’s site, checked November 2, 2026. Check the maker’s page for who can use it.

Authorized genericNot sold

There isn’t one. An authorized generic is Aldurazyme itself, from the same company, sold without the brand name, and usually for less. For now Aldurazyme is the only choice; its maker’s savings card can lower what you pay.

See the brand name →

Regular genericNot sold

Aldurazyme is a biologic. Biologics don’t have generics, but some have biosimilars or an unbranded version from the same maker. Ask your pharmacist or prescriber whether one is sold. Generics usually come once the brand’s patents and exclusivity end. Until then, the maker’s savings card is the way to pay less.

See the brand name →

What it’s used for

Mucopolysaccharidosis I (MPS I)

What the FDA label says

ALDURAZYME is a hydrolytic lysosomal glycosaminoglycan (GAG)-specific enzyme indicated for the treatment of adult and pediatric patients with Hurler and Hurler-Scheie forms of Mucopolysaccharidosis I (MPS I) and for the treatment of patients with the Scheie form of MPS I who have moderate to severe symptoms.

Limitations of Use:

The risks and benefits of treating mildly affected patients with the Scheie form have not been established.
ALDURAZYME has not been evaluated for effects on the central nervous system manifestations of the disorder.

Source: the FDA label for Aldurazyme (Genzyme Corporation), September 11, 2026. Full label on DailyMed

Good to know

“Commercial insurance” means a plan from a job, from the marketplace, or one you buy yourself. A retiree plan that’s part of Medicare counts as Medicare. Check the maker’s page for who can use it.
Most cards need a sign-up on the maker’s site, and many work only if your plan covers the drug. Then give the card’s details to the clinic’s billing office.
Don’t stop or change a medicine without talking to your pharmacist or prescriber.

Prices checked November 2, 2026. Prices change: confirm with the pharmacy before you fill. drugalt.com/drug/aldurazyme/